Joanne M. Ferrell
Analyst Joanne M. Ferrell assists pharmaceutical companies and contract research organizations (CROs) comply with regulatory agency requirements. In particular, she helps companies develop and initiate programs and monitoring systems to ensure comprehensive and efficient methods of pharmaceutical adverse event monitoring for pharmacovigilant requirements.
Ms. Ferrell assists CROs with alternatives for animal model research as required by IACUC and OLAW, and she provides insight and analysis regarding toxicology, clinical trials, pharmacokinetics, and intellectual property. She partners with medical, nutraceutical, pharmaceutical, animal health and biological companies to assess R&D strategies and competitive market information.
Ms. Ferrell has nearly 20 years of experience at clinical research centers including Michigan State University Clinical Center, where she worked in weekly clinics held for oncology, allergy, and infertility, as well as disorders of hematology and coagulation. Ms. Ferrell’s areas of expertise include pharmaceuticals, toxicology, herbs, nutraceuticals, wound healing, animal health, disease models, microbiology, infection control, blood banking, clinical laboratory analysis, quality control, and instrumentation.
She holds a bachelor’s degree in medical technology from Salve Regina College and is a member of the American Society of Clinical Pathologists.
- B.S., Medical Technology, Salve Regina College
- Member, American Society of Clinical Pathologists
- Bridgers, A, Ferrell, JM, “Drug Manufacturers Should Seek Outside Services to Monitor Adverse Events”, Nerac Insights, http://www.nerac.com/nerac_insights.php?category=articles&id=149, December 2008
- Ferrell, JM, “Think Negative: Wound Therapy Could Save Billions in Healthcare Costs”, Nerac Insights, http://www.nerac.com/nerac_insights.php?category=articles&id=45, June 2008